Nivolumab Combined With Paclitaxel Plus Ramucirumab as Second-Line Treatment in Advanced Gastric Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Multicenter Phase I/II Study of Nivolumab Combined With Paclitaxel Plus Ramucirumab as Second-Line Treatment in Patients With Advanced Gastric Cancer
Clin. Cancer Res 2020 Dec 01;[EPub Ahead of Print], TE Nakajima, S Kadowaki, K Minashi, T Nishina, T Yamanaka, Y Hayashi, N Izawa, K Muro, S Hironaka, T Kajiwara, Y KawakamiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.